Showing 1 - 2 results of 2 for search 'Irfan Qureshi, M.D.', query time: 0.02s Refine Results
  1. 1
    Safety and Tolerability of BHV-7000, a Novel Kv7 Potassium Channel Activator: Results from Phase 1 Single and Multiple Ascending Dose Studies

    Safety and Tolerability of BHV-7000, a Novel Kv7 Potassium Channel Activator: Results from Phase 1 Single and Multiple Ascending Dose Studies by Bharat Awsare, M.D., Jason Lerner, M.D., Eric Ashbrenner, M.S., Heather Sevinsky, M.S., Michael Bozik, M.D., Steven Dworetzky, Ph.D., Lia Donahue, M.A., Randall Killingsworth, B.A., Bruno Francoeur, M.D., Irfan Qureshi, M.D.

    Published 2024-07-01
    Get full text
    Article
  2. 2
    BHV-7000, A Novel, Selective Kv7.2/7.3 Potassium Channel Activator, Demonstrates Dose-Dependent Pharmacodynamic Effects on EEG Parameters in Healthy Adults

    BHV-7000, A Novel, Selective Kv7.2/7.3 Potassium Channel Activator, Demonstrates Dose-Dependent Pharmacodynamic Effects on EEG Parameters in Healthy Adults by Jason Lerner, M.D., Bharat Awsare, M.D., Heather Sevinsky, M.S., Eric Ashbrenner, M.S., Randall Killingsworth, B.A., Racheal Kendrick, PharmD, Emiel Vereycken, M.S., Nigel Colenbier, Ph.D., Caroline Neuray, M.D., Pieter van Mierlo, Ph.D., Jeremy Slater, M.D., David Wyatt, M.D., Irfan Qureshi, M.D., Steven Dworetzky, Ph.D., Michael Bozik, M.D.

    Published 2024-07-01
    Get full text
    Article

Search Tools: